UNSPSC 51292916: Dibenzepin

This classification denotes a dibenzazepine and tricyclic antidepressive agent with the molecular formula C18H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 510SJZ1Y6L, chemically known as 5,10-dihydro-10-(2-(dimethylamino)ethyl)-5-methyl-11h-dibenzo(b,e)(1,4)diazepin-11-one but generally known as dibenzepin, which bears US NIH Compound Identifier 9419. European Medicines Agency schedules Dibenzepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07074MIG.

UNSPSC 51292916 Dibenzepin is a Commodity code that maps to pharmaceutical and medical supply procurement, though the recent state and local activity under this code shows limited direct relevance to the code's nominal scope. Seminole County, Florida's IFB60459723LAS solicitation, posted in June 2026 with a July 2023 response deadline, sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—a community health and emergency response procurement rather than dibenzepin specifically. The mismatch between the code classification and actual solicitation content suggests either a tagging anomaly or a misalignment between the UNSPSC taxonomy applied and the goods actually being purchased. The Seminole County opportunity required electronic bid submission through the county's e-Procurement Portal, included quarterly delivery obligations to a specified community health facility, and mandated vendor compliance with drug-free workplace certification, E-Verify requirements, and multiple insurance coverages (workers' compensation, commercial general liability, and professional liability). The contract structure included an initial two-year term with a one-year renewal option and a three-month probationary termination provision.

The source presents only one recent opportunity under this code and does not support a characterization of broader geographic spread or issuing-body mix across state and local jurisdictions. Seminole County, Florida is the sole identified buyer in the recent-opportunities record. The code shows limited recent activity, and the single posted opportunity does not align clearly with dibenzepin procurement. Business development professionals should verify whether this code is the correct vehicle for their pharmaceutical or emergency-response medical supply offerings, or whether opportunities under this taxonomy are currently sparse in the state and local market.